Total Funding
16
39
Total FundingEquity Crowdfunding raised
Growth Score
-3 pts
Heat Score
-20 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
105930
Quadrant Biosciences is an epigenetic diagnostics company focusing on the early detection of neurological disorders.
Richard Uhlig: CEO & FounderPast Role: Federal Reserve Bank of New York, Head of Liquidity Risk
Nick Gianadda: Chief Technology OfficerPast Role: Field Nimble, CTO
About the Company
Quadrant Biosciences specializes in epigenetic diagnostics with a primary focus on the early identification of neurological disorders and addressing significant healthcare challenges. The company is dedicated to improving lives by delivering innovative diagnostic, therapeutic, and virtual care solutions for global health priorities.
